Behringwerke conducted initial experiments in heat treatment. Read more about Behringwerke conducted initial experiments in heat treatment.
Dr Peter Fernandes accidently discovered an appropriate stabiliser and by December 1978 had moved on to show those which worked with the globulin could work with antihaemophilic factor. Read more about Dr Peter Fernandes accidently discovered an appropriate stabiliser and by December 1978 had moved on to show those which worked with the globulin could work with antihaemophilic factor.
The Committee on Safety of Medicines considered the safety of heat-treated Factor 8. Read more about The Committee on Safety of Medicines considered the safety of heat-treated Factor 8.
An internal Cutter memo showed that all heat-treated product made commercially carried a significant, though reduced, risk of hepatitis. None had been eliminated. Read more about An internal Cutter memo showed that all heat-treated product made commercially carried a significant, though reduced, risk of hepatitis. None had been eliminated.
Dr Harris of Armour wrote to haemophilia centre directors recommending the return of all non-donor tested Factorate so that it could be exchanged for material manufactured from screened donations. Read more about Dr Harris of Armour wrote to haemophilia centre directors recommending the return of all non-donor tested Factorate so that it could be exchanged for material manufactured from screened donations.
Dr Edward Shanbrom, who worked as a vice-president of medical and scientific affairs at Hyland, developed the first commercially marketed freeze-dried Factor 8 concentrate. However his suggestions only attracted minimal support in the 1970s and very early 1980s. Read more about Dr Edward Shanbrom, who worked as a vice-president of medical and scientific affairs at Hyland, developed the first commercially marketed freeze-dried Factor 8 concentrate. However his suggestions only attracted minimal support in the 1970s and very early 1980s.
Leveton and others published "HIV and the Blood Supply: An Analysis of Crisis Decisionmaking". Read more about Leveton and others published "HIV and the Blood Supply: An Analysis of Crisis Decisionmaking".
Experiments were conducted by Dr Shohachi Wada on behalf of Cutter to see if the hepatitis virus with which Factor 9 was spiked could be inactivated whilst the Fator 9 was kept active. Read more about Experiments were conducted by Dr Shohachi Wada on behalf of Cutter to see if the hepatitis virus with which Factor 9 was spiked could be inactivated whilst the Fator 9 was kept active.
Dr Peter Foster stated in his oral evidence to the Inquiry that it was difficult dealing with a possible virus, the structure of which was unknown. However, both BPL and PFC managed to inactivate NANBH before the structure of Hepatitis C was known. Read more about Dr Peter Foster stated in his oral evidence to the Inquiry that it was difficult dealing with a possible virus, the structure of which was unknown. However, both BPL and PFC managed to inactivate NANBH before the structure of Hepatitis C was known.
Christopher Bishop asserted in his oral evidence that Armour had done: "everything possible to provide the best possible treatment and the most up-to-date systems in accordance with the state of art at that time." Read more about Christopher Bishop asserted in his oral evidence that Armour had done: "everything possible to provide the best possible treatment and the most up-to-date systems in accordance with the state of art at that time."